US4450154A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Antitumor hybrid and process for the preparation thereof
Assignee: Teijin Ltd
•
Filing: 1981-12-21
•
Granted: 1984-05-22
•
Expires: 2001-12-21
Abstract
Abstract Antitumor protein hybrid, composed of a moiety which is substantially the fragment Fab of an antitumor immunogloblin and a moiety which is the subunit A of ricin, which is expressed by the following formula (I): Fab-S.sub.1 --(X).sub.n --S.sub.2 --RA).sub.m . . . (I) (where Fab indicates a moiety which is substantially the fragment Fab of an antitumor immunogloblin; RA indicates a moiety which is the subunit A of ricin; X indicates a divalent organic radical; S 1 and S 2 are both sulfur atoms, S 1 indicating a sulfur atom arising from the disulfide bond (--S--S-- bond) in an immunoglobulin and S 2 a sulfur atom arising from the disulfide bond in ricin; n stands for 0 or 1 and m stands for an integer of 1 to 5). This antitumor protein hybrid has remarkable and specific cytotoxicity against tumor cells.
Inventors
- 👤 Yasuhiko Masuho
- 👤 Takeshi Hara
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 10:04
CPC Classifications
A; A61; A61K; A61K47/00; A61K47/50; A61K47/51; A61K47/68; A61K47/6801; A61K47/6803; A61K47/6811; A61K47/6817; A61K47/6819; A61K47/6825; A61K47/6827; A61K47/6889; Y; Y10; Y10S; Y10S530/00; Y10S530/866
Claims Analysis
Total Claims: 5
Claim 1
Independent Claim
139 words
A process for preparing an antitumor protein hybrid which is expressed by the following formula (II'), which process comprises reacting the substantial fragment Fab of an antitumor immunogloblin which has at least one S-sulfo radical or an active disulfide radical expressed by the following formula (V) with the subunit A of ricin which has at least one thiol radical in the fragment: --S--Z (V) where Z indicates ##STR4## wherein Fab indicates a moiety which is substantially the fragment Fab of an antitumor immunoglobulin; RA indicates a moiety which is the subunit A of ricin; S 1 and S 2 are both sulfur atoms, S 1 indicating a sulfur atom arising fron the disulfide bond in the immunoglobulin and S 2 a sulfur atom arising from the disulfide bond in ricin; and m represents an integer of 1 to 5.
Claim 2
Dependent Claim
139 words
A process for preparing an antitumor protein hybrid which is expressed by the following formula (II'), which process comprises reacting the substantial fragment Fab of an antitumor immunogloblin which has at least one S-sulfo radical or an active disulfide radical expressed by the following formula (V) with the subunit A of ricin which has at least one thiol radical in the fragment: --S--Z (V) where Z indicates ##STR4## wherein Fab indicates a moiety which is substantially the fragment Fab of an antitumor immunoglobulin; RA indicates a moiety which is the subunit A of ricin; S 1 and S 2 are both sulfur atoms, S 1 indicating a sulfur atom arising fron the disulfide bond in the immunoglobulin and S 2 a sulfur atom arising from the disulfide bond in ricin; and m represents an integer of 1 to 5.
Claim 3
Dependent Claim
155 words
A process for preparing an antitumor protein hybrid which is expressed by the following formula (I'), which process comprises binding the substantial fragment Fab of an antitumor immunoglobulin which has at least one thiol radical in the fragment with the subunit A of ricin which has at least one thiol radical in the fragment with the use of a compound which has at least two functional groups capable of reacting with a thiol radical Fab--S.sub.1 --X--S.sub.2 --RA).sub.m (I') wherein Fab indicates a moiety which is substantially the fragment Fab of an antitumor immunoglobulin; RA indicates a moiety which is the subunit A of ricin; X indicates a divalent organic radical; S 1 and S 2 are both sulfur atoms, S 1 indicating a sulfur atom arising from the disulfide bond in the immunoglobulin and S 2 a sulfur atom arising from the sulfide bond in ricin; and m represents a integer of 1 to 5.
Claim 4
Dependent Claim
155 words
A process for preparing an antitumor protein hybrid which is expressed by the following formula (I'), which process comprises binding the substantial fragment Fab of an antitumor immunoglobulin which has at least one thiol radical in the fragment with the subunit A of ricin which has at least one thiol radical in the fragment with the use of a compound which has at least two functional groups capable of reacting with a thiol radical Fab--S.sub.1 --X--S.sub.2 --RA).sub.m (I') wherein Fab indicates a moiety which is substantially the fragment Fab of an antitumor immunoglobulin; RA indicates a moiety which is the subunit A of ricin; X indicates a divalent organic radical; S 1 and S 2 are both sulfur atoms, S 1 indicating a sulfur atom arising from the disulfide bond in the immunoglobulin and S 2 a sulfur atom arising from the sulfide bond in ricin; and m represents a integer of 1 to 5.
Claim 5
Dependent Claim
29 words
The process of claim 1, wherein said substantial fragment Fab of an antitumor immunogloblin is the substantial fragment Fab of an antitumor immunogloblin having at least one S-sulfo radical.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-05-22 | 1987-11-21 | 1988-05-22 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-05-22 | 1991-11-21 | 1992-05-22 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-05-22 | 1995-11-21 | 1996-05-22 | $7700.00 | Window Closed / Lapsed |